Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Reading Hospital and Medical Center

About this trial

The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.

Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.

Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.

Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of Type 2 Diabetes with HA1c >8.0

Current patients of the Family Healthcare Center, Reading Hospital Tower health.

Disqualifiers

Identified special populations (pregnancy or individuals currently incarcerated)

Patients without access to their own smart phone

Any patient who is unable to provide their own informed consent to participate in the study

Trial design

Treatments tested in this trial

  • Diabetes education web site application

Treatment groups

65 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The Reading Hospital and Medical Center

Lead sponsor

Reading Hospital Foundation

Collaborator

Complete Statistical Services (Consult-Stat)

Collaborator